THE VACCINE BOOKLET REFERENCES

INTRODUCTION

1. Hooker et al, Sage Open Medicine, 2020; Analysis of health outcomes in vaccinated and unvaccinated children
2. Miller et al, Cureus, 2023; Neonatal, Infant, and Under Age Five Vaccine Doses Routinely Given in Developed Nations and Their Association With Mortality Rates
3. Electronic Support for Public Health–Vaccine Adverse Event Reporting System
4. Albonico et al, Science Direct, Oct 1998; Febrile infectious childhood diseases in the history of cancer patients and matched control
5. Rosenlund et al, Pediatrics, Mar 2009; Allergic disease and atopic sensitization in children in relation to measles vaccination and measles infection
6. Ritchie et al, Our World in Data, 2021; Unsafe sanitation is a leading risk factor for death
7. Levin, Food Drug Law, 2015; Closing the Door to Lost Earnings Under the National Childhood Vaccine Injury Act of 1986
8. National Library of Medicine; Liability of the Production and Sale of Vaccines
9. Fortune Business Insights, Pharmaceutical/Vaccines Market
10. Jama Network, Nov 2020; Financial Penalties Imposed on Large Pharmaceutical Firms for Illegal Activities
11. National Vaccine Injury Compensation Program Monthly Statistics
12. Irish Times, Aug 2023; Plan for vaccine-damages scheme stalls despite ‘priority’ pledge
13. Leading lobbying industries in the United States in 2022, Statista.com
14. Statistica; Direct-to-consumer spending of the pharmaceutical industry in the United States from 2012 to 2021
15. American Academy of Paediatrics current partners
16. Demasi, British Medical Journal, 2022; From FDA to MHRA, are drug regulators for hire?
17. Salmon et al, NEJM, Jul 2024; Funding Postauthorization Vaccine-Safety Science
18. AbbVie Clinical Trials; How long do clinical trials take?
19. European Medicines Agency (EMA) Guideline on clinical evaluation of vaccines
20. Rid et al, Recommendations of a WHO expert panel, Vaccine Vol 32, Issue 37, 2014; Placebo use in vaccine trials
21. HSE, 2016; Adverse events following immunisation, Common and Uncommon
22. McKenna, Feb 2018 Catholic Medical Association; Use of Aborted Fetal Tissue in Vaccines and Medical Research Obscures the Value of All Human Life
23. Warfving et al, International Journal of Vaccines and Vaccination, Vol 4 Issue 2, 2017; Short review of aluminium hydroxide..
24. Guimaraes et al; Science Direct Vol 100, Oct 2015; Vaccines, adjuvants and autoimmunity
25. Tomljenovic et al, Vol 18, Iss 17, 2011; Vaccine adjuvants: are they safe?

CHICKENPOX/ VARICELLA

1. Health Information and Quality Authority (HIQA), July 2023; HIQA publishes HTA on the addition of the chickenpox vaccine to the childhood immunisation programme
2. Goldman et al, Sage Journals, Nov 2013; Vaccination to prevent varicella: Goldman and King’s response to Myers’ interpretation of Varicella Active Surveillance Project data

COVID (PFIZER COMIRNATY / NUVAXOVID)

1. Ioannidis, Oct 2022; Age-stratified infection fatality rate of COVID-19 in the non-elderly population
2. Pineles et al, Annals of Internal Medicine, Vol 174, No 12, Dec 2021; In-Hospital Mortality in a Cohort of Hospitalized Pregnant and Nonpregnant Patients With COVID-19
3. Chemaitelly et al, Nature, June 2022; Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar
4. Shrestha et al, open Forum Infectious Diseases, Vol 10 Issue 6, Jun 2023; Effectiveness of the Coronavirus Disease 2019 Bivalent Vaccine
5. Letter to the BMJ, Aug 2023; We need proper explanations for apparent COVID-19 vaccine negative effectiveness
6. Olliaro et al, Lancet Volume 2, Issue 7 Jul 2021; COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room
7. CDC Covid-19 Variant Update
8. Public Health and Medical Professionals for Transparency; www.phmpt.org
9. Reuters, Jan 2022; Judge orders FDA to hasten release of Pfizer vaccine docs
10. NBC FDA to authorize new covid booster without trials in people
11. Buergin et al, Wiley, Jul 2023; Sex-specific differences in myocardial injury incidence after COVID-19 mRNA-1273 booster vaccination
12. Mansanguan et al, Journals of Tropical Medicine Vol 7 Issue 8, Aug 2022; Cardiovascular Manifestation of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents
13. Kwan et al, Nature, Dec 2022; Apparent risks of postural orthostatic tachycardia syndrome diagnoses after COVID-19 vaccination and SARS-Cov-2 Infection
14. Röltgen et al, CellPress, Mar 2022; Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination
15. Brogna et al, Proteomics, Clinical Applications, Nov 2023; Detection of recombinant Spike protein in the blood of individuals vaccinated against SARS-CoV-2: Possible molecular mechanisms
16. Yonker et al, American Heart Association Journals, Volume 147, Number 11, Jan 2023 ; Circulating Spike Protein Detected in Post–COVID-19 mRNA Vaccine Myocarditis
17. Speicher et al, OSF Preprints, Oct 2023; DNA fragments detected in monovalent and bivalent Pfizer/BioNTech and Moderna modRNA COVID-19 vaccines from Ontario, Canada: Exploratory dose response relationship with serious adverse events
18. Wong et al, Lancet, Aug 2022; Menstrual irregularities and vaginal bleeding after COVID-19 vaccination reported to v-safe active surveillance, USA in December, 2020–January, 2022: an observational cohort study
19. Thorp et al, Preprints, June 2024; Are COVID-19 Vaccines in Pregnancy as Safe and Effective as the U.S. Government, Medical Organizations, and Pharmaceutical Industry Claim? Part I
20. Thorp et al, Preprints, June 2024; Are COVID-19 Vaccines in Pregnancy as Safe and Effective as the U.S. Government, Medical Organizations, and Pharmaceutical Industry Claim? Part II
21. Kuhbandner and Reitzner, Cureus, May 2023; Estimation of Excess Mortality in Germany During 2020-2022

DIPHTHERIA, TETANUS, POLIO, PERTUSSIS, HEP B, HIB (BOOSTRIX 3-in-1 / Infanrix Hexa 6-in-1 / TETRAVAC 4-in-1)

1. Journal of Bacteriology, Aug 1978, Vol. 135, No. 2; Evidence that the regulation of diphtheria toxin production is directed at the level of transcription
2. Puliyel and Sathyamala, Indian Journal of Medical Ethics, Sep 2017; Infanrix hexa and sudden death: a review of the periodic safety update reports submitted to the European Medicines Agency
3. Zinka et al, Vaccine, Aug 2006; Unexplained cases of sudden infant death shortly after hexavalent vaccination
4. European Centre for Disease Prevention and Control website; Disease information about Invasive Haemophilus influenzae disease
5. Ormerod et al, The Canadian Medical Association, 1937; Ascorbic Acid (vitamin C treatment of whooping cough
6. CBS News, Feb 2019; LA Countrywide whooping cough outbreak hits exclusive school
7. Althouse, BMC Medicine, June 2015; Asymptomatic transmission and the resurgence of Bordetella pertussis
8. Mehndiratta et al, The Neurohospitalist, Oct 2014; Poliomyelitis
9. University of Dhaka and infectious disease, Jun 1984; Effect of ascorbic acid in the treatment of tetanus

iNFLUENZA (QUADRIVALENT / INFLUVAX / FLUENZ )

1. Yu et al, Nature, 2012; Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors
2. HSE Flu Symptoms and Diagnosis
3. The Irish Times, Jan 2011; The HSE changes policy for pregnant women
4. Jefferson et al, Cochrane Database, Feb 2018; Vaccines for preventing influenza in healthy children
5. Yan et al, Biological Sciences Vol 115, No 5, Dec 2017; Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community
6. Cowling et al, Oxford Academics Jun 2012; Increased Risk of Noninfluenza Respiratory Virus Infections Associated With Receipt of Inactivated Influenza Vaccine
7. Keeley et al, Journal of Infectious Diseases, Vol 228, Issue 7, Oct 2023; Streptococcus pyogenes Colonization in Children Aged 24-59 Months in the Gambia
8. Levin et al, Science Direct Volume 26, Issue 33, 5 August 2008; Shedding of Live Vaccine Virus, Comparative Safety, and Influenza-Specific Antibody Responses after Administration of Live Attenuated and Inactivated Trivalent Influenza Vaccines to HIV-Infected Children
9. Clinical Infectious Diseases, Volume 56, Issue 10, 15 May 2013; Influenza Vaccine Effectiveness in the Community and the Household

MEASLES, MUMPS and RUBELLA (M-M-RvaxPro / priorix)

1. D’Souza et al, Journal of Tropical Pediatrics, Dec 2002; Vitamin A for the treatment of children with measles–a systematic review
2. Hussey, British Medical Journal, 1997; Managing measles
3. Green Book of Immunisation, Dec 2019; Chapter 21 Measles
4. Glasziou et al, British Medical Journal, 1993; Vitamin A supplementation in infectious diseases: a meta-analysis.
5. Rosenlund et al, Pediatrics, Mar 2009; Allergic disease and atopic sensitization in children in relation to measles vaccination and measles infection
6. Sasco et al, American Journal of Epidemiology, Dec 1985; Measles infection and Parkinson’s disease
7. Kubota et al, Atherosclerosis, Aug 2015; Association of measles and mumps with cardiovascular disease: The Japan Collaborative Cohort (JACC) study
8. Montella et al, Leukemia Research, Aug 2006; Do childhood diseases affect NHL and HL risk? A case-control study from northern and southern Italy
9. Cann et al, Cancer Detection and Protection, Feb 2006; Acute infections as a means of cancer prevention: opposing effects to chronic infections?
10. Klein et al, Journal of the Pediatric Infectious Diseases Society, Mar 2019; Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Consistency Study.
11. Beleni et al, International journal of environmental research and public health, July 2018; Mumps in the Vaccination Age: Global Epidemiology and the Situation in Germany
12. Masarani et al, Journal of the Royal Society of Medicine, Nov 2006; Mumps orchitis
13. West, Cancer: an international interdisciplinary journal of the American Cancer Society, July 1996; Epidemiologic study of malignancies of the ovaries
14. NBC News, Dec 2021; Majority of mumps cases are among the vaccinated, CDC finds
15. Pan American Health Organisation, Apr 2017
16. WHO Measles and Rubella: regional and country profiles
17. Harrison’s Principles of Internal Medicine

Meningococcal (bexsero / menjugate)

1. Caugant et al, Vaccine, Jun 2024; Meningococcal carriage and disease—Population biology and evolution
2. Ala’Aldeen et al, Journal of Clinical Microbiology, June 2000, Dynamics of Meningococcal Long-Term Carriage among University Students and Their Implications for Mass Vaccination
3. European Centre for Disease Prevention and Control (ECDC); Vaccine schedules in all countries in the EU/EEA

Pneumococcal (prevenar13)

1. CDC website, May 2024; Chapter 17: Pneumococcal Disease
2. WHO Factsheet, Nov 22; Pneumonia in Children
3. Selbing et al, The Lancet, Vol 345, March 1995; Increase in bacteraemic pneumococcal infections in children
4. Hemila et al, Cochrane, Aug 2018; Vitamin C for prevention and treating pneumonia
5. European Centre for Disease Prevention and Control (ECDC), Invasive pneumococcal disease – Annual Epidemiological Report for 2018

Respiratory Syncytial Virus (RSV) (nirsevimab)

1. Centre for Disease Control (US) website; How RSV Spreads
2. Young, Infectious Disease, Mar 2021; Socioeconomic Impact of RSV Hospitalization
3. Mosscrop, Nature, Jul 2022; Respiratory syncytial virus after the SARS-CoV-2 pandemic — what next?
4. Department of Health, June 2024; Minister for Health announces government approval for a new Respiratory Syncytial Virus (RSV) Immunisation Pathfinder Programme
5. Nirsevimab Summary of Product Characteristics (SmPC)
6. Antimicrobial Drugs Advisory Committee Meeting, Jun 2023; FDA Briefing Document
7. Berrod, Le Parisien, Sep 2024; Bronchiolite : que disent les premières données sur les effets indésirables du Beyfortus?
8. European Centre for Disease Control, Respiratory syncytial Virus (RSV)

Rotavirus (rotarix)

• John Hopkins University; The Epidemiology and Disease Burden of Rotavirus
• Murphy et al, Vaccine Vol 41, Issue 16, April 2023; The economic impact of the introduction of universal rotavirus
• FDA Package Insert Rotarix
• The Pediatric Infectious Disease Journal Burden of rotavirus disease in EU countries

Vitamin K (KONAKION)

1. World Health Organisation, 2014; Guideline: Delayed Umbilical Cord Clamping for Improved Maternal and Infant Health and Nutrition Outcomes.
2. Nutrients, May 2018; Maternal Circulating Vitamin Status and Colostrum Vitamin Composition in Healthy Lactating Women—A Systematic Approach
3. Paediatrics, Issue 149, Volume 3, March 2022; Vitamin K and the Newborn Infant
4. Enkin et al, Wiley, Jun 1995; Effective Care in Pregnancy and Childbirth: A Synopsis
5. Wickham, Vitamin K and the newborn, 2005; Page 73
6. HSE website archive; Vitamin K for newborns
7. NHS website; Vitamin K deficiency of the newborn
8. Sanker et al, Journal of Perinatology, May 2016; Vitamin K prophylaxis for prevention of vitamin K deficiency bleeding: a systematic review
9. Britt and Brown, Clinical and applied thrombosis/hemostasis journal, Jan 2018; Characterizing the Severe Reactions of Parenteral Vitamin K1
10. Drugs.com; Phytonadione (Injection)